Aim of the study: To reassess the imprecision and Limit of Quantitation, to evaluate the cross-reaction with dehydroepiandrosterone-sulfate (DHEAS), the accuracy toward liquid chromatography-mass spectrometry (LC-MS) and the reference interval of the Access 
| INTRODUCTION
Testosterone is the principal androgen hormone, and is produced mainly in the male by the Leydig testis cells. It is also present in the female as intermediate metabolite of the estrogens synthesis and derived by androstenedione by peripheral conversion. 1 The testosterone determination can be used in the delayed puberty, in primary or secondary hypogonadism and in some female endocrine disorders, as hirsutism, virilization and/or in polycystic ovarian syndrome. 2 It is worth noting that, so far, no reliable routine methods for direct determination of active testosterone free form are available, 3 and it is to date suggested the estimate of bioavailable testosterone through total testosterone determination and the mainly binding protein, the Sex Hormone Binding Globulin. 4 However, the commonly used immunometric assays for testosterone measurement could show limited sensitivity and accuracy at clinically relevant levels.
One of the reasons of these analytical drawbacks could be interferences from other steroid hormones. In particular, dehydroepiandrosterone-sulfate (DHEAS), although structurally less similar to testosterone in respect to other steroids, could significantly cross-react with testosterone measurements due to its relatively high circulating concentrations, on average of three orders of magnitude greater than those of the testosterone. 5 Aim of the study is to re-evaluate the technical characteristics of one automatic immunometric testosterone assays (Access Testosterone from Beckman-Coulter), in particular as for accuracy (in comparison with an LC-MS determination) and DHEAS cross-reaction, reported in Instruction for Use as "0.0%", with an approximation rate that could be misleading. 
| MATERIALS AND METHODS

| Testosterone determination
| Imprecision
Imprecision at different concentration was evaluated testing six pool samples (S1, S2, S3, S4, S5 and S6) stored in aliquots at −20°C for a maximum of 30 days and assayed in 20 different runs using two different reagents lots, according to CLSI EP-5 protocol. 6 Moreover, the pool from S1 to S5 were used to built an imprecision profile and derive a measure of LoQ at 20% of Coefficient of Variation, according to the CLSI EP17-A2 guideline. 
| Cross-reaction with Dehydroepiandosteronesulphate (DHEAS)
The cross-reaction with DHEAS was studied by a displacement curve, assaying with testosterone reagent two standard curves (testosterone and DHEAS), and evaluating the ratio between the concentration of the two analytes that causes the halving of the binding capacity respect to "zero" dose. 
| Liquid chromatography-mass spectrometry evaluation
Comparison with LC-MS assay was performed on 21 routine samples no preservative substances were added to the control samples. 
| Indirect reference interval verification
The reference interval was verified by the indirect estimation, as previously reported. Information System and subdivided into males aged over 14 years and females. Outliers, identified by using the iterative 4 SD rule, and data from subjects who had repeated measurements within the observation period were excluded.
| Statistical analysis
Performed with MedCalc © Software, Version 7.4.2.0 (MedCalc Software, Mariakerke, Belgium).
| RESULTS
| Analytical performances
Six pools results showed a coefficient of variation between 2.7% and 34.7% (Table 1) .
From the results of the pools from S1 to S5 we built a precision profile, and by fitting a power function to the data we could derive a . A similar trend is also observed using the consensus mean of all laboratories using Access DxI method (data not shown).
| Verification of reference interval
Extracted results were subdivided into females and males over 14 years old. Outliers were removed from each group by using the iterative 4 SD rule. The group of males aged over 14 years showed a bimodal distribution, and the group with the lowest concentration The standard curves of testosterone (filled squares) and DHEAS prepared in testosterone-free matrix (filled circles) were assayed with testosterone reagent and the results were reported as percentage of Bound/B 0 . The cross-reactivity was defined as a percentage of the concentration of DHEAS at the point where the reduction in signal reach the 50% of the binding capacity (50% of the signal achieved in the absence of analyte), respect to the concentration of testosterone giving the same fall in signal. The concentrations are indicated by the arrows
| DISCUSSION
Our study confirms adequate analytical performances of Access Testosterone assay, in terms of precision, sensitivity, and accuracy.
We confirm the DHEAS interference, which resulted of a similar magnitude to that previously found. 5 Due to tested cross-reactivity, in typical health adult male the increase of testosterone concentration can be <10% even with very high DHEAS amounts. In prepubescent children or females, conversely, DHEAS presence should be considered, as apparent and clinically relevant testosterone increase could be found in case of extremely high DHEAS levels. However, also given the nonconstant trend of the displacement curve, it can be calculated that under 7000 nmol/L of DHEAS the interference extension could be negligible for the majority of the clinical needs.
LC-MS method comparison gives overall data well correlated, at
least within the limits of our evaluation. This finding is in accord with other recent studies, 11, 12 that, using different immunometric platforms, report both analytically and clinically acceptable correlation with mass-spectrometry methods, although at low concentrations the relationships are weaker and more scattered. However, considering the interferences from other steroid hormones that affect the immunoassays testosterone determination, the relative underestimation found in this paper in comparison with LC-MS is unexpected.
The comparison was evaluated also in a subset of samples used in the framework of the Immunocheck EQAS program, and for which a In conclusion, the Access Testosterone method could be considered an adequately reliable tool for the testosterone measurement.
The interference from DHEAS, although it must be taken into account, does not seem to overly influence the determination. 
